Assessing the ISPOR HEOR Competencies Framework in the Real World Could Inform Postgraduate Training
The Professional Society for Health Economics and Outcomes Research (ISPOR) has organized 41 competencies across 13 topics into the ISPOR [...]
Former CDC Scientist and Stanford Epidemiologist Discusses Controversial Obesity Article
Dr. Katherine Flegal discusses the widespread controversy surrounding her article on mortality associated with obese and overweight people. At the [...]
Register for Upcoming ISPOR Signal Event on Current HEOR Trends and Applying New Big Data Tools
Register today for a virtual ISPOR event that will take place from 11:00 AM to 12:30 PM EDT on September [...]
Improving Science Communication Using Visuals
An on-demand video highlights the importance of scientific communication and how incorporating visuals can improve the user experience. The use [...]
Wyden’s Principles of Reform Include a US-Based Drug Pricing System
Senator Wyden is pushing for legislation that will reduce prescription drug prices, such as Biogen’s pricy Aduhelm. He’s noted that [...]
10-Year Hydrocortisone Tablet Overcharge and Pay-For-Delay Deal Lead to £266.4 Million in Fines
The UK Competition and Markets Authority (CMA) has fined hydrocortisone tablet manufacturers £266.4 million for overcharging the National Health Service [...]
New ISPOR Article Discusses Survey on the Impact of COVID-19 on HTAs and Payers
A new article, published in ISPOR’s Value in Health journal, discusses how the COVID-19 pandemic has impacted health technology assessments [...]
Register Today for Upcoming ISPOR Short Course on Applied Cost-Effectiveness Modeling with R
ISPOR will host a virtual short course on August 11th and 12th from 10:00 AM to 12:00 PM EDT. The [...]
Productive Medication Not Priced To the Low Revenue Client
Productive Medication Not Priced To the Low Revenue Client There are many new Organic medication authorised through the FDA to [...]
Wyden Seeks to Include Medicare Price Negotiation in Healthcare Legislation
Senate Finance Committee Chair Ron Wyden was adamant in his support for legislation that would allow Medicare to negotiate drug [...]
What insurers’ premium rate filings can tell us about predicted health utilization in 2022
Payers are expecting healthcare utilization to return to pre-pandemic levels, and as a result, are not factoring in additional costs [...]
Effective Medications Not Priced For The Minimal Profits Consumer
Effective Medications Not Priced For The Minimal Profits Consumer There are many new biological prescription drugs authorized because of the [...]
UK Seeks to Advance Cost-Effective Rare Disease Research, Allocates $340 Million to New Innovative Medicines Fund
The UK will expand its Cancer Drugs Fund by creating a new Innovative Medicines Fund. The fund will promote research [...]
A Comprehensive Study Explore How Specialty Pharmacy Services Market Will Grow In Future
A Comprehensive Study Explore How Specialty Pharmacy Services Market Will Grow In Future The Latest survey report on Global Specialty [...]
AI and Machine Learning Expected to Modernize Global Healthcare Supply Chain
The global healthcare supply chain that provides reliable medications to patients when and where they need them will be modernized [...]
5 Essential Steps to Address Access Barriers Beyond Coverage
For years, payer strategies in the U.S. have had just one goal in mind: gaining access to the market for [...]
Widespread Price-Gouging of COVID-19 Tests Continues According to New AHIP Study
A recent study conducted by America’s Health Insurance Plans (AHIP) found that healthcare systems continue to up-charge for COVID-19 tests, [...]
According to pharmaceuticals journals, what are the latest developments in the industry?
According to pharmaceuticals journals, what are the latest developments in the industry? Right now, tech-based sectors are evolving at a [...]
Mikaela Odlander Of Orexo: “Leverage the digital advances in healthcare”
Leverage the digital advances in healthcare. Today you can get help for so many things through non-traditional ways by either [...]
Bellwether biosim case? Not really, as Pfizer and J&J settle high-profile Remicade lawsuit on undisclosed terms
For nearly four years, pharmaceutical heavyweights Johnson & Johnson and Pfizer have sparred in court over competitive dynamics of the biosimilar [...]
Better together: McCann and FCB health chiefs talk strategy and strengths in creating IPG Health
With 39 agencies now under its collective umbrella, there aren’t many pharma marketing challenges that the new IPG Health can’t [...]
How one startup foretold the neuroscience renaissance after ’50 years of shitshow’
In the past couple of years, something curious has happened: Pharma and VC dollars started gushing into neuroscience research. Biogen’s [...]
Fight over “pay for delay” heats up in Washington
After being left to the courts for a decade, reverse settlement deals between generic and brand pharmaceutical companies, dubbed “pay [...]
Radar on Market Access: Executive Order Revives Standardized ACA Exchange Plans
In President Joe Biden’s new executive order aimed at promoting competition in the American economy, he directs HHS Secretary Xavier [...]
What is Expected growth in Health Economics & Outcomes Research (HEOR) Services Market Trends and Prospects 2027?
Global Health Economics & Outcomes Research (HEOR) Services 2020 by Manufacturers, Regions, Type and Application, Forecast to 2027 A new [...]